{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:29:48Z","timestamp":1792931388604,"version":"4.5.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The accelerating rate of antibiotic resistance has always been one of the leading causes of increased skin and soft tissue infections (SSTIs) burden around the globe. Current treatments mainly focus on systemic antibiotics indicated for both uncomplicated and complicated SSTIs that act as a contributing factor secondary to widespread systemic exposure. Topical formulation of antibacterial agents or antibiotics are renowned for their targeted and localised action in the skin which appears as an intriguing clue to the resistance problem. Nevertheless, there are several deterrents associated with conventional topical formulations including drug permeability and skin retention. This has propelled the transformation of SSTI intervention towards the incorporation of nanotechnology to enhance topical drug delivery for SSTIs. This review outlines the advancement of nanoparticle-based topical formulations against SSTIs, covering cellulitis and erysipelas, boils and carbuncles, impetigo, cutaneous non-tuberculous mycobacterial infections and leprosy, as well as pitted keratolysis. Pre-clinical safety profile and antibacterial efficacy of topical nanoformulations were comprehensively reviewed and classified into multiple categories such as metal nanoparticles, emulsion-based nanosystems, nanovesicles, lipid nanoparticles and polymeric nanoparticles. The up-to-date patent trends on topical nanoformulations for SSTIs up to 2025 were also analysed and justified based on current evidence to pinpoint the research gap and future prospects in this growing area of research. It is anticipated that topical nanoformulations can potentially stand in for conventional topical formulations to treat SSTIs attributed to their pronounced antibacterial activity and tolerability.<\/jats:p>","DOI":"10.1007\/s13346-025-01924-7","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T22:42:53Z","timestamp":1752878573000},"page":"4141-4186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Progress in topical nanoformulations against bacterial skin and soft tissue infections\u2013 current trends"],"prefix":"10.1007","volume":"15","author":[{"given":"Michelle Zhi Yee","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooi Leong","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bey Hing","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-0849","authenticated-orcid":false,"given":"Lay Hong","family":"Chuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"1924_CR1","doi-asserted-by":"crossref","unstructured":"Esposito S, Noviello S, Leone S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2).","DOI":"10.1097\/QCO.0000000000000239"},{"key":"1924_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0924-8579(09)70541-2","volume":"34","author":"MS Dryden","year":"2009","unstructured":"Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents. 2009;34:S2\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"1924_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.18773\/austprescr.2016.058","volume":"39","author":"V Sukumaran","year":"2016","unstructured":"Sukumaran V, Senanayake S. Bacterial skin and soft tissue infections. Aust Prescr. 2016;39(5):159\u201363.","journal-title":"Aust Prescr"},{"key":"1924_CR4","doi-asserted-by":"crossref","unstructured":"Linz MS, Mattappallil A, Finkel D, Parker D. Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiot [Internet]. 2023; 12(3).","DOI":"10.3390\/antibiotics12030557"},{"key":"1924_CR5","unstructured":"Stevens DL, Bryant AE, Impetigo. Erysipelas and cellulitis. University of Oklahoma Health Sciences Center, Oklahoma City (OK); 2016."},{"key":"1924_CR6","doi-asserted-by":"publisher","first-page":"861115","DOI":"10.3389\/fmed.2022.861115","volume":"9","author":"Y Xue","year":"2022","unstructured":"Xue Y, Zhou J, Xu BN, Li Y, Bao W, Cheng XL, et al. Global burden of bacterial skin diseases: A systematic analysis combined with sociodemographic index, 1990\u20132019. Front Med (Lausanne). 2022;9:861115.","journal-title":"Front Med (Lausanne)"},{"key":"1924_CR7","doi-asserted-by":"publisher","first-page":"1374466","DOI":"10.3389\/fmicb.2024.1374466","volume":"15","author":"A Elfadadny","year":"2024","unstructured":"Elfadadny A, Ragab RF, AlHarbi M, Badshah F, Ib\u00e1\u00f1ez-Arancibia E, Farag A, et al. Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol. 2024;15:1374466.","journal-title":"Front Microbiol"},{"issue":"4","key":"1924_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/0113816128326718240809091654","volume":"31","author":"A Mishra","year":"2025","unstructured":"Mishra A, Jyoti A, Aayush K, Saxena J, Sharma K. Harnessing nanoparticles to overcome antimicrobial resistance: promises and challenges. Curr Pharm Des. 2025;31(4):292\u2013306.","journal-title":"Curr Pharm Des"},{"issue":"12","key":"1924_CR9","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1128\/AAC.00649-12","volume":"56","author":"F Marra","year":"2012","unstructured":"Marra F, Patrick David M, Chong M, McKay R, Hoang L, Bowie William R. Population-Based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use. Antimicrob Agents Chemother. 2012;56(12):6243\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1924_CR10","doi-asserted-by":"crossref","unstructured":"Burillo A, Pulido-P\u00e9rez A, Bouza E. Current challenges in acute bacterial skin infection management. Curr Opin Infect Dis. 2024;37(2).","DOI":"10.1097\/QCO.0000000000000989"},{"issue":"3","key":"1924_CR11","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1080\/09546634.2020.1859442","volume":"33","author":"MH Storandt","year":"2022","unstructured":"Storandt MH, WC D, E. SA, and, Beal JR. Trends and risk factors in the antibiotic management of skin and soft tissue infections in the united States. J Dermatol Treat. 2022;33(3):1576\u201380.","journal-title":"J Dermatol Treat"},{"issue":"1","key":"1924_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12879-016-2067-0","volume":"16","author":"TL Walsh","year":"2016","unstructured":"Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN, et al. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infect Dis. 2016;16(1):721.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1924_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2174\/157341312801784221","volume":"8","author":"P Prabhu","year":"2012","unstructured":"Prabhu P, Patravale V, Joshi M. Nanocarriers for effective topical delivery of anti-infectives. Curr Nanosci. 2012;8(4):491\u2013503.","journal-title":"Curr Nanosci"},{"key":"1924_CR14","doi-asserted-by":"crossref","unstructured":"Sangnim T, Puri V, Dheer D, Venkatesh DN, Huanbutta K, Sharma A. Nanomaterials in the wound healing process: new insights and advancements. Pharmaceutics. 2024;16(3).","DOI":"10.3390\/pharmaceutics16030300"},{"issue":"1","key":"1924_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/1040841X.2017.1313811","volume":"44","author":"PL Lam","year":"2018","unstructured":"Lam PL, Lee KKH, Wong RSM, Cheng GYM, Bian ZX, Chui CH, et al. Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns. Crit Rev Microbiol. 2018;44(1):40\u201378.","journal-title":"Crit Rev Microbiol"},{"issue":"2","key":"1924_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/1574891X13666180529103804","volume":"13","author":"K Thakur","year":"2018","unstructured":"Thakur K, Sharma G, Singh B, Chhibber S, Katare OP. Current state of nanomedicines in the treatment of topical infectious disorders. Recent Pat Antiinfect Drug Discov. 2018;13(2):127\u201350.","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"1924_CR17","doi-asserted-by":"publisher","first-page":"107455","DOI":"10.1016\/j.micpath.2025.107455","volume":"203","author":"MA Obeid","year":"2025","unstructured":"Obeid MA, Alyamani H, Alenaizat A, Tun\u00e7 T, Aljabali AAA, Alsaadi MM. Nanomaterial-based drug delivery systems in overcoming bacterial resistance: current review. Microb Pathog. 2025;203:107455.","journal-title":"Microb Pathog"},{"issue":"45","key":"1924_CR18","doi-asserted-by":"publisher","first-page":"33568","DOI":"10.1039\/D4RA06117A","volume":"14","author":"R Solanki","year":"2024","unstructured":"Solanki R, Makwana N, Kumar R, Joshi M, Patel A, Bhatia D, et al. Nanomedicines as a cutting-edge solution to combat antimicrobial resistance. RSC Adv. 2024;14(45):33568\u201386.","journal-title":"RSC Adv"},{"key":"1924_CR19","unstructured":"Morris AD. Cellulitis and erysipelas. BMJ Clin Evid. 2008;2008."},{"issue":"8","key":"1924_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00403-024-03317-1","volume":"316","author":"Z Shu","year":"2024","unstructured":"Shu Z, Cao J, Li H, Chen P, Cai P. Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials. Arch Dermatol Res. 2024;316(8):603.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"1924_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s15010-022-01842-7","volume":"50","author":"K Yadav","year":"2022","unstructured":"Yadav K, Krzyzaniak N, Alexander C, Scott AM, Clark J, Glasziou P, et al. The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis. Infection. 2022;50(4):859\u201371.","journal-title":"Infection"},{"issue":"5","key":"1924_CR22","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jaad.2020.11.021","volume":"84","author":"Z Ren","year":"2021","unstructured":"Ren Z, Silverberg JI. Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting. J Am Acad Dermatol. 2021;84(5):1496\u2013503.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1924_CR23","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.5001\/omj.2022.11","volume":"37","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Sil A, Bhanja DB, Panigrahi A. Butterfly rash. Oman Med J. 2022;37(4):e411.","journal-title":"Oman Med J"},{"key":"1924_CR24","unstructured":"CDC. Clinical Guidance for Group A Streptococcal Cellulitis. U.S. Centers for Disease Control and Prevention. Updated March 1, 2024. Accessed April 20. 2025. https:\/\/www.cdc.gov\/group-a-strep\/hcp\/clinical-guidance\/cellulitis.html#:~:text=Treatment%20options,susceptible%20to%20beta%2Dlactam%20antibiotics"},{"issue":"2","key":"1924_CR25","first-page":"Cd013099","volume":"2","author":"HS Lin","year":"2021","unstructured":"Lin HS, Lin PT, Tsai YS, Wang SH, Chi CC. Interventions for bacterial folliculitis and boils (furuncles and carbuncles). Cochrane Database Syst Rev. 2021;2(2):Cd013099.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1924_CR26","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):e10\u201352.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1924_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.annemergmed.2017.07.483","volume":"71","author":"DA Talan","year":"2018","unstructured":"Talan DA, Moran GJ, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, et al. Subgroup analysis of antibiotic treatment for skin abscesses. Ann Emerg Med. 2018;71(1):21\u201330.","journal-title":"Ann Emerg Med"},{"issue":"7","key":"1924_CR28","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/emermed-2013-202571","volume":"31","author":"AJ Singer","year":"2014","unstructured":"Singer AJ, Thode HC Jr. Systemic antibiotics after incision and drainage of simple abscesses: a meta-analysis. Emerg Med J. 2014;31(7):576\u20138.","journal-title":"Emerg Med J"},{"issue":"8","key":"1924_CR29","doi-asserted-by":"publisher","first-page":"e0136789","DOI":"10.1371\/journal.pone.0136789","volume":"10","author":"AC Bowen","year":"2015","unstructured":"Bowen AC, Mah\u00e9 A, Hay RJ, Andrews RM, Steer AC, Tong SY, et al. The global epidemiology of impetigo: A systematic review of the population prevalence of impetigo and pyoderma. PLoS ONE. 2015;10(8):e0136789.","journal-title":"PLoS ONE"},{"issue":"6","key":"1924_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.clinthera.2021.04.013","volume":"43","author":"G Gahlawat","year":"2021","unstructured":"Gahlawat G, Tesfaye W, Bushell M, Abrha S, Peterson GM, Mathew C, et al. Emerging treatment strategies for impetigo in endemic and nonendemic settings: A systematic review. Clin Ther. 2021;43(6):986\u20131006.","journal-title":"Clin Ther"},{"issue":"1","key":"1924_CR31","first-page":"Cd003261","volume":"1","author":"S Koning","year":"2012","unstructured":"Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1(1):Cd003261.","journal-title":"Cochrane Database Syst Rev"},{"key":"1924_CR32","doi-asserted-by":"crossref","unstructured":"Zulu M, Monde N, Nkhoma P, Malama S, Munyeme M. Nontuberculous mycobacteria in humans, animals, and water in zambia: A systematic review. Front Trop Dis. 2021;Volume 2\u20132021.","DOI":"10.3389\/fitd.2021.679501"},{"issue":"3","key":"1924_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/ijmr.IJMR_902_20","volume":"152","author":"SK Sharma","year":"2020","unstructured":"Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152(3):185\u2013226.","journal-title":"Indian J Med Res"},{"key":"1924_CR34","doi-asserted-by":"crossref","unstructured":"Wang SH, Pancholi P. Mycobacterial skin and soft tissue infection. Curr Infect Dis Rep. 2014;16(11).","DOI":"10.1007\/s11908-014-0438-5"},{"key":"1924_CR35","doi-asserted-by":"crossref","unstructured":"George M. Cutaneous non-tuberculous mycobacterial infections: an update. Journal of Skin and Sexually Transmitted Diseases.5.","DOI":"10.25259\/JSSTD_52_2022"},{"issue":"3","key":"1924_CR36","doi-asserted-by":"publisher","first-page":"102655","DOI":"10.1016\/j.jiph.2025.102655","volume":"18","author":"J Zhou","year":"2025","unstructured":"Zhou J, Jia Q, Liu L, Liang L, Zhang H, He C, et al. Epidemiology and clinical outcomes in skin and soft tissue nontuberculous mycobacteria infections: A retrospective study. J Infect Public Health. 2025;18(3):102655.","journal-title":"J Infect Public Health"},{"issue":"6","key":"1924_CR37","doi-asserted-by":"publisher","first-page":"ofaa173","DOI":"10.1093\/ofid\/ofaa173","volume":"7","author":"CE Hannah","year":"2020","unstructured":"Hannah CE, Ford BA, Chung J, Ince D, Wanat KA. Characteristics of nontuberculous mycobacterial infections at a Midwestern tertiary hospital: A retrospective study of 365 patients. Open Forum Infect Dis. 2020;7(6):ofaa173.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"1924_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.det.2015.03.017","volume":"33","author":"TM Gonzalez-Santiago","year":"2015","unstructured":"Gonzalez-Santiago TM, Drage LA. Nontuberculous mycobacteria: skin and soft tissue infections. Dermatol Clin. 2015;33(3):563\u201377.","journal-title":"Dermatol Clin"},{"issue":"4","key":"1924_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1924_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clindermatol.2014.07.002","volume":"33","author":"C Talhari","year":"2015","unstructured":"Talhari C, Talhari S, Penna GO. Clinical aspects of leprosy. Clin Dermatol. 2015;33(1):26\u201337.","journal-title":"Clin Dermatol"},{"issue":"8","key":"1924_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/20477724.2022.2057722","volume":"116","author":"J Yang","year":"2022","unstructured":"Yang J, Li X, Sun Y, Zhang L, Jin G, Li G, et al. Global epidemiology of leprosy from 2010 to 2020: A systematic review and meta-analysis of the proportion of sex, type, grade 2 deformity and age. Pathog Glob Health. 2022;116(8):467\u201376.","journal-title":"Pathog Glob Health"},{"key":"1924_CR42","unstructured":"WHO. Leprosy. World Health Organization, Updated. January 24, 2025. Accessed April 20, 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leprosy"},{"issue":"12","key":"1924_CR43","first-page":"1","volume":"12","author":"LL Chaves","year":"2020","unstructured":"Chaves LL, Patriota Y, Soares-Sobrinho JL, Vieira ACC, Costa Lima SA, Reis S. Drug delivery systems on leprosy therapy. Mov Towards Eradication?? Pharm. 2020;12(12):1\u201319.","journal-title":"Mov Towards Eradication?? Pharm"},{"issue":"5","key":"1924_CR44","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/bjd.16923","volume":"179","author":"S Bunyaratavej","year":"2018","unstructured":"Bunyaratavej S, Leeyaphan C, Chanyachailert P, Pattanaprichakul P, Ongsri P, Kulthanan K. Clinical manifestations, risk factors and quality of life in patients with pitted keratolysis: a cross-sectional study in cadets. Br J Dermatol. 2018;179(5):1220\u20131.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1924_CR45","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1046\/j.1365-2672.2002.01742.x","volume":"93","author":"CM Longshaw","year":"2002","unstructured":"Longshaw CM, Wright JD, Farrell AM, Holland KT. Kytococcus sedentarius, the organism associated with pitted keratolysis, produces two keratin-degrading enzymes. J Appl Microbiol. 2002;93(5):810\u20136.","journal-title":"J Appl Microbiol"},{"issue":"3","key":"1924_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0378-6323.16250","volume":"71","author":"G Singh","year":"2005","unstructured":"Singh G, Naik CL. Pitted keratolysis. Indian J Dermatol Venereol Leprol. 2005;71(3):213\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"9","key":"1924_CR47","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ced\/llad175","volume":"48","author":"V Palaniappan","year":"2023","unstructured":"Palaniappan V, Murthy AB, Karthikeyan K. Pitted keratolysis. Clin Exp Dermatol. 2023;48(9):978\u201383.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"1924_CR48","first-page":"287","volume":"43","author":"MC Ezebuenyi","year":"2018","unstructured":"Ezebuenyi MC, Brakta F, Onor IO, Sarpong DF, Bryant-Burks K, Figueroa JE 2. Evaluation of physician prescribing patterns for antibiotics in the treatment of nonnecrotizing skin and soft tissue infections. P T. 2018;43(5):287\u201392.","journal-title":"P T"},{"issue":"3","key":"1924_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jamda.2016.09.024","volume":"18","author":"D Feldstein","year":"2017","unstructured":"Feldstein D, Sloane PD, Weber D, Ward K, Reed D, Zimmerman S. Current prescribing practices for skin and soft tissue infections in nursing homes. J Am Med Dir Assoc. 2017;18(3):265\u201370.","journal-title":"J Am Med Dir Assoc"},{"key":"1924_CR50","doi-asserted-by":"crossref","unstructured":"Furukawa D, Graber CJ. No to Pip-Tazo: identifying inappropriate use of Piperacillin-Tazobactam for treatment of skin and soft tissue infections. Infect Dis Clin Pract. 2017;25(4).","DOI":"10.1097\/IPC.0000000000000499"},{"issue":"10","key":"1924_CR51","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1473-3099(20)30084-0","volume":"20","author":"SW de Jonge","year":"2020","unstructured":"de Jonge SW, Boldingh QJJ, Solomkin JS, Dellinger EP, Egger M, Salanti G, et al. Effect of postoperative continuation of antibiotic prophylaxis on the incidence of surgical site infection: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20(10):1182\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1924_CR52","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40257-024-00856-1","volume":"25","author":"R Salle","year":"2024","unstructured":"Salle R, Del Giudice P, Skayem C, Hua C, Chosidow O. Secondary bacterial infections in patients with atopic dermatitis or other common dermatoses. Am J Clin Dermatol. 2024;25(4):623\u201337.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"1924_CR53","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijantimicag.2017.12.013","volume":"51","author":"E Carrara","year":"2018","unstructured":"Carrara E, Pfeffer I, Zusman O, Leibovici L, Paul M. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis. Int J Antimicrob Agents. 2018;51(4):548\u201353.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"1924_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jiph.2013.04.010","volume":"6","author":"C Meddles-Torres","year":"2013","unstructured":"Meddles-Torres C, Hu S, Jurgens C. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus. J Infect Public Health. 2013;6(6):423\u201330.","journal-title":"J Infect Public Health"},{"issue":"1","key":"1924_CR55","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.annemergmed.2019.12.012","volume":"76","author":"JP Haran","year":"2020","unstructured":"Haran JP, Goulding M, Campion M, Scully G, Chandra A, Goldberg R, et al. Reduction of inappropriate antibiotic use and improved outcomes by implementation of an Algorithm-Based clinical guideline for nonpurulent skin and soft tissue infections. Ann Emerg Med. 2020;76(1):56\u201366.","journal-title":"Ann Emerg Med"},{"issue":"11","key":"1924_CR56","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.ajic.2017.05.013","volume":"45","author":"JA Gibbons","year":"2017","unstructured":"Gibbons JA, Smith HL, Kumar SC, Duggins KJ, Bushman AM, Danielson JM, et al. Antimicrobial stewardship in the treatment of skin and soft tissue infections. Am J Infect Control. 2017;45(11):1203\u20137.","journal-title":"Am J Infect Control"},{"key":"1924_CR57","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ajem.2020.10.017","volume":"46","author":"L May","year":"2021","unstructured":"May L, Nguyen MH, Trajano R, Tancredi D, Aliyev ER, Mooso B, et al. A multifaceted intervention improves antibiotic stewardship for skin and soft tissues infections. Am J Emerg Med. 2021;46:374\u201381.","journal-title":"Am J Emerg Med"},{"key":"1924_CR58","doi-asserted-by":"crossref","unstructured":"Smith R, Russo J, Fiegel J, Brogden N. Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails. Antibiot [Internet]. 2020; 9(2).","DOI":"10.3390\/antibiotics9020056"},{"key":"1924_CR59","doi-asserted-by":"crossref","unstructured":"Iliopoulos F, Sil BC, Evans CL. The role of excipients in promoting topical and transdermal delivery: current limitations and future perspectives. Front Drug Delivery. 2022;Volume 2\u20132022.","DOI":"10.3389\/fddev.2022.1049848"},{"issue":"3","key":"1924_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cmi.2024.09.025","volume":"31","author":"T T\u00e4ngd\u00e9n","year":"2025","unstructured":"T\u00e4ngd\u00e9n T, Carrara E, Hellou MM, Yahav D, Paul M. Introducing new antibiotics for multidrug-resistant bacteria: Obstacles and the way forward. Clin Microbiol Infect. 2025;31(3):354\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1924_CR61","doi-asserted-by":"publisher","first-page":"1493915","DOI":"10.3389\/fcimb.2025.1493915","volume":"15","author":"A Yarahmadi","year":"2025","unstructured":"Yarahmadi A, Najafiyan H, Yousefi MH, Khosravi E, Shabani E, Afkhami H, et al. Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review. Front Cell Infect Microbiol. 2025;15:1493915.","journal-title":"Front Cell Infect Microbiol"},{"key":"1924_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2018.01.011","volume":"127","author":"J Marto","year":"2018","unstructured":"Marto J, Ruivo E, Lucas SD, Gon\u00e7alves LM, Sim\u00f5es S, Gouveia LF, et al. Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance. Eur J Pharm Biopharm. 2018;127:1\u201311.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"1924_CR63","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s11095-010-0292-6","volume":"28","author":"YB Choy","year":"2011","unstructured":"Choy YB, Prausnitz MR. The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal. Pharm Res. 2011;28(5):943\u20138.","journal-title":"Pharm Res"},{"key":"1924_CR64","doi-asserted-by":"crossref","unstructured":"Abruzzo A, Parolin C, Rossi M, Vitali B, Cappadone C, Bigucci F. Development and characterization of Azithromycin-Loaded microemulsions: A promising tool for the treatment of bacterial skin infections. Antibiotics. 2022;11(8).","DOI":"10.3390\/antibiotics11081040"},{"issue":"1","key":"1924_CR65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/08982104.2021.1955925","volume":"32","author":"HA El-Hashemy","year":"2022","unstructured":"El-Hashemy HA. Design, formulation and optimization of topical ethosomes using full factorial design: in-vitro and ex-vivo characterization. J Liposome Res. 2022;32(1):74\u201382.","journal-title":"J Liposome Res"},{"key":"1924_CR66","doi-asserted-by":"crossref","unstructured":"Khasawneh DM, Oweis RJ, Alsmadi M. A comprehensive analysis of Liposomal-Based nanocarriers for treating skin and soft tissue infection. Curr Drug Deliv. 2024.","DOI":"10.2174\/0115672018328954240801110200"},{"issue":"5","key":"1924_CR67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1208\/s12249-023-02563-2","volume":"24","author":"S Karnam","year":"2023","unstructured":"Karnam S, Jindal AB, Agnihotri C, Singh BP, Paul AT. Topical nanotherapeutics for treating MRSA-Associated skin and soft tissue infection (SSTIs). AAPS PharmSciTech. 2023;24(5):108.","journal-title":"AAPS PharmSciTech"},{"key":"1924_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jcis.2024.02.099","volume":"663","author":"S Pushpa Ragini","year":"2024","unstructured":"Pushpa Ragini S, Dyett BP, Sarkar S, Zhai J, White JF, Banerjee R, et al. A systematic study of the effect of lipid architecture on cytotoxicity and cellular uptake of cationic cubosomes. J Colloid Interface Sci. 2024;663:82\u201393.","journal-title":"J Colloid Interface Sci"},{"key":"1924_CR69","doi-asserted-by":"crossref","unstructured":"Bueno J, Demirci F, Baser KHC. Antimicrobial Strategies in Novel Drug Delivery Systems: Applications in the Treatment of Skin and Soft Tissue Infections2017. 271\u2013\u200986 p.","DOI":"10.1016\/B978-0-12-811079-9.00016-1"},{"key":"1924_CR70","doi-asserted-by":"crossref","unstructured":"Toader G, Podaru IA, Rusen E, Diacon A, Ginghina RE, Alexandru M et al. Nafcillin-Loaded photocrosslinkable nanocomposite hydrogels for biomedical applications. Pharmaceutics. 2023;15(6).","DOI":"10.3390\/pharmaceutics15061588"},{"issue":"2","key":"1924_CR71","doi-asserted-by":"publisher","first-page":"e1852","DOI":"10.1002\/wnan.1852","volume":"15","author":"AC Mengarda","year":"2023","unstructured":"Mengarda AC, Iles B, Longo JPF, de Moraes J. Recent approaches in nanocarrier-based therapies for neglected tropical diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(2):e1852.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1924_CR72","doi-asserted-by":"crossref","unstructured":"Dikshit PK, Kumar J, Das AK, Sadhu S, Sharma S, Singh S et al. Green Synthesis of Metallic Nanoparticles: Applications and Limitations. Catalysts [Internet]. 2021; 11(8).","DOI":"10.3390\/catal11080902"},{"key":"1924_CR73","doi-asserted-by":"publisher","first-page":"104165","DOI":"10.1016\/j.jddst.2023.104165","volume":"80","author":"H Li","year":"2023","unstructured":"Li H, You Q, Feng X, Zheng C, Zeng X, Xu H. Effective treatment of Staphylococcus aureus infection with silver nanoparticles and silver ions. J Drug Deliv Sci Technol. 2023;80:104165.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"1924_CR74","doi-asserted-by":"publisher","first-page":"863","DOI":"10.4103\/2141-9248.144883","volume":"4","author":"J Sharifi-Rad","year":"2014","unstructured":"Sharifi-Rad J, Hoseini Alfatemi S, Sharifi Rad M, Iriti M. Antimicrobial synergic effect of allicin and silver nanoparticles on skin infection caused by Methicillin-Resistant Staphylococcus aureus spp. Ann Med Health Sci Res. 2014;4(6):863\u20138.","journal-title":"Ann Med Health Sci Res"},{"key":"1924_CR75","doi-asserted-by":"crossref","unstructured":"Mikhailova EO. Silver nanoparticles: mechanism of action and probable Bio-Application. J Funct Biomater. 2020;11(4).","DOI":"10.3390\/jfb11040084"},{"key":"1924_CR76","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijpharm.2019.04.068","volume":"564","author":"M Mohseni","year":"2019","unstructured":"Mohseni M, Shamloo A, Aghababaie Z, Afjoul H, Abdi S, Moravvej H, et al. A comparative study of wound dressings loaded with silver sulfadiazine and silver nanoparticles: in vitro and in vivo evaluation. Int J Pharm. 2019;564:350\u20138.","journal-title":"Int J Pharm"},{"issue":"4","key":"1924_CR77","first-page":"2189","volume":"27","author":"K Sitlaothaworn","year":"2019","unstructured":"Sitlaothaworn K, Dechkla M. Efficacy of Silvernano bacterial cellulose insole on micrococcus sedentarius growth. Pertanika J Sci Technol. 2019;27(4):2189\u2013200.","journal-title":"Pertanika J Sci Technol"},{"issue":"3","key":"1924_CR78","doi-asserted-by":"publisher","first-page":"280","DOI":"10.15386\/mpr-2750","volume":"97","author":"MC Crisan","year":"2024","unstructured":"Crisan MC, Pandrea SL, Matros L, Mocan T, Mocan L. In vitro antimicrobial activity of silver nanoparticles against selected Gram-negative and Gram-positive pathogens. Med Pharm Rep. 2024;97(3):280\u201397.","journal-title":"Med Pharm Rep"},{"key":"1924_CR79","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ijbiomac.2018.05.057","volume":"116","author":"A Shah","year":"2018","unstructured":"Shah A, Hussain I, Murtaza G. Chemical synthesis and characterization of chitosan\/silver nanocomposites films and their potential antibacterial activity. Int J Biol Macromol. 2018;116:520\u20139.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"1924_CR80","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s10904-020-01603-9","volume":"30","author":"M Ijaz","year":"2020","unstructured":"Ijaz M, Zafar M, Islam A, Afsheen S, Iqbal T. A review on antibacterial properties of biologically synthesized zinc oxide nanostructures. J Inorg Organomet Polym Mater. 2020;30(8):2815\u201326.","journal-title":"J Inorg Organomet Polym Mater"},{"issue":"null","key":"1924_CR81","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.2147\/IJN.S216204","volume":"14","author":"B Lallo da Silva","year":"2019","unstructured":"Lallo da Silva B, Paiva AM, Eloisa BM, Augusto OJJ, Galdorfini C-AB, PRCL R, et al. Relationship between structure and antimicrobial activity of zinc oxide nanoparticles: an overview. Int J Nanomed. 2019;14(null):9395\u2013410.","journal-title":"Int J Nanomed"},{"key":"1924_CR82","doi-asserted-by":"crossref","unstructured":"Mandal AK, Katuwal S, Tettey F, Gupta A, Bhattarai S, Jaisi S et al. Current research on zinc oxide nanoparticles: synthesis, characterization, and biomedical applications. Nanomaterials [Internet]. 2022; 12(17).","DOI":"10.3390\/nano12173066"},{"issue":"58","key":"1924_CR83","doi-asserted-by":"publisher","first-page":"36361","DOI":"10.1039\/C7RA05040B","volume":"7","author":"MA Rauf","year":"2017","unstructured":"Rauf MA, Owais M, Rajpoot R, Ahmad F, Khan N, Zubair S. Biomimetically synthesized ZnO nanoparticles attain potent antibacterial activity against less susceptible: S. aureus skin infection in experimental animals. RSC Adv. 2017;7(58):36361\u201373.","journal-title":"RSC Adv"},{"issue":"6","key":"1924_CR84","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.24200\/sci.2021.56815.4974","volume":"28","author":"K Dhanasegaran","year":"2022","unstructured":"Dhanasegaran K, Djearamane S, Liang SXT, Wong LS, Kasivelu G, Lee PF, et al. Antibacterial properties of zinc oxide nanoparticles on Pseudomonas aeruginosa (ATCC 27853). SCIENTIA IRANICA. 2022;28(6):3806\u201315.","journal-title":"SCIENTIA IRANICA"},{"key":"1924_CR85","doi-asserted-by":"crossref","unstructured":"Wo\u017aniak-Budych MJ, Staszak K, Staszak M. Copper and Copper-Based nanoparticles in Medicine\u2014Perspectives and challenges. Molecules [Internet]. 2023; 28(18).","DOI":"10.3390\/molecules28186687"},{"issue":"13","key":"1924_CR86","doi-asserted-by":"publisher","first-page":"135101","DOI":"10.1088\/0957-4484\/25\/13\/135101","volume":"25","author":"AK Chatterjee","year":"2014","unstructured":"Chatterjee AK, Chakraborty R, Basu T. Mechanism of antibacterial activity of copper nanoparticles. Nanotechnology. 2014;25(13):135101.","journal-title":"Nanotechnology"},{"issue":"3","key":"1924_CR87","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5530\/ijper.54.3.113","volume":"54","author":"V Verma","year":"2020","unstructured":"Verma V, Kaushik D. Mupirocin mounted copper nanoparticle offered augmented drug delivery against resistant bacteria. Indian J Pharm Educ Res. 2020;54(3):637\u201346.","journal-title":"Indian J Pharm Educ Res"},{"issue":"3","key":"1924_CR88","doi-asserted-by":"publisher","first-page":"101885","DOI":"10.1016\/j.jksus.2022.101885","volume":"34","author":"M Narayanan","year":"2022","unstructured":"Narayanan M, hussain FJ, Srinivasan B, Sambantham MT, Al-Keridis LA, Al-mekhlafi FA. Green synthesizes and characterization of copper-oxide nanoparticles by Thespesia populnea against skin-infection causing microbes. J King Saud Univ Sci. 2022;34(3):101885.","journal-title":"J King Saud Univ Sci"},{"issue":"1","key":"1924_CR89","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.drudis.2019.09.020","volume":"25","author":"E Alphand\u00e9ry","year":"2020","unstructured":"Alphand\u00e9ry E. Iron oxide nanoparticles for therapeutic applications. Drug Discov Today. 2020;25(1):141\u20139.","journal-title":"Drug Discov Today"},{"issue":"2","key":"1924_CR90","doi-asserted-by":"publisher","first-page":"e1592","DOI":"10.1002\/wnan.1592","volume":"12","author":"Y Abo-zeid","year":"2020","unstructured":"Abo-zeid Y, Williams GR. The potential anti\u2010infective applications of metal oxide nanoparticles: A systematic review. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(2):e1592.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1924_CR91","doi-asserted-by":"publisher","first-page":"724499","DOI":"10.3389\/fbioe.2021.724499","volume":"9","author":"S Pan","year":"2021","unstructured":"Pan S, Goudoulas TB, Jeevanandam J, Tan KX, Chowdhury S, Danquah MK. Therapeutic applications of metal and metal-oxide nanoparticles: Dermato-cosmetic perspectives. Front Bioeng Biotechnol. 2021;9:724499.","journal-title":"Front Bioeng Biotechnol"},{"key":"1924_CR92","doi-asserted-by":"crossref","unstructured":"Munoz LN, Jaramillo V, Gantiva-Diaz M, Cifuentes J, Munoz-Camargo C, Cruz JC, et al. Formulation of a novel antibacterial topical treatment based on Magnetite-Buforin-II-silver nanobioconjugates. Volume 10. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY; 2022.","DOI":"10.3389\/fbioe.2022.1003004"},{"key":"1924_CR93","doi-asserted-by":"publisher","first-page":"102300","DOI":"10.1016\/j.mtchem.2024.102300","volume":"41","author":"W Hu","year":"2024","unstructured":"Hu W, Ouyang Q, Jiang C, Huang S, Alireza N-E, Guo D, et al. Biomedical Metal\u2013Organic framework materials on antimicrobial therapy: perspectives and challenges. Mater Today Chem. 2024;41:102300.","journal-title":"Mater Today Chem"},{"key":"1924_CR94","doi-asserted-by":"publisher","first-page":"215431","DOI":"10.1016\/j.ccr.2023.215431","volume":"496","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu J, Li W, Li J, Han H, Song Z. Responsive metal\u2013organic framework nanocarrier delivery system: an effective solution against bacterial infection. Coord Chem Rev. 2023;496:215431.","journal-title":"Coord Chem Rev"},{"issue":"5","key":"1924_CR95","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1039\/C8TX00087E","volume":"7","author":"N Bhardwaj","year":"2018","unstructured":"Bhardwaj N, Pandey SK, Mehta J, Bhardwaj SK, Kim K-H, Deep A. Bioactive nano-metal\u2013organic frameworks as antimicrobials against Gram-positive and Gram-negative bacteria. Toxicol Res. 2018;7(5):931\u201341.","journal-title":"Toxicol Res"},{"issue":"3","key":"1924_CR96","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1039\/C3TB20832J","volume":"2","author":"C Tamames-Tabar","year":"2014","unstructured":"Tamames-Tabar C, Cunha D, Imbuluzqueta E, Ragon F, Serre C, Blanco-Prieto MJ, et al. Cytotoxicity of nanoscaled metal\u2013organic frameworks. J Mater Chem B. 2014;2(3):262\u201371.","journal-title":"J Mater Chem B"},{"key":"1924_CR97","doi-asserted-by":"publisher","first-page":"119620","DOI":"10.1016\/j.ijpharm.2020.119620","volume":"586","author":"HA Fathi","year":"2020","unstructured":"Fathi HA, Abdelkader A, AbdelKarim MS, Abdelaziz AA, El-Mokhtar MA, Allam A, et al. Electrospun vancomycin-loaded nanofibers for management of methicillin-resistant Staphylococcus aureus-induced skin infections. Int J Pharm. 2020;586:119620.","journal-title":"Int J Pharm"},{"issue":"29","key":"1924_CR98","doi-asserted-by":"publisher","first-page":"33802","DOI":"10.1021\/acsami.1c06308","volume":"13","author":"H Luo","year":"2021","unstructured":"Luo H, Lan H, Cha R, Yu X, Gao P, Zhang P, et al. Dialdehyde nanocrystalline cellulose as antibiotic substitutes against multidrug-resistant bacteria. ACS Appl Mater Interfaces. 2021;13(29):33802\u201311.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"39","key":"1924_CR99","doi-asserted-by":"publisher","first-page":"25798","DOI":"10.1021\/acsami.6b09267","volume":"8","author":"X Dai","year":"2016","unstructured":"Dai X, Guo Q, Zhao Y, Zhang P, Zhang T, Zhang X, et al. Functional silver nanoparticle as a benign antimicrobial agent that eradicates Antibiotic-Resistant Bacteria and promotes wound healing. ACS Appl Mater Interfaces. 2016;8(39):25798\u2013807.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"1924_CR100","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1080\/02648725.2023.2216419","volume":"40","author":"SK Behera","year":"2024","unstructured":"Behera SK, Huwaikem M, Jena B, Shah MP, Chakrabortty S, Tripathy SK, et al. Fabrication of zno\/gypsum\/gelatine nanocomposites films and their antibacterial mechanism against Staphylococcus aureus. Biotechnol Genet Eng Rev. 2024;40(4):4713\u201336.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"1924_CR101","doi-asserted-by":"crossref","unstructured":"Almostafa MM, Elsewedy HS, Shehata TM, Soliman WE. Novel formulation of fusidic acid incorporated into a Myrrh-Oil-Based nanoemulgel for the enhancement of skin bacterial infection treatment. GELS. 2022;8(4).","DOI":"10.3390\/gels8040245"},{"issue":"71","key":"1924_CR102","doi-asserted-by":"publisher","first-page":"43894","DOI":"10.1039\/D0RA04807K","volume":"10","author":"S Azhar","year":"2020","unstructured":"Azhar S, Ashari SE, Ahmad S, Salim N. In vitro kinetic release study, antimicrobial activity and in vivo toxicity profile of a Kojic acid ester-based nanoemulsion for topical application. RSC Adv. 2020;10(71):43894\u2013903.","journal-title":"RSC Adv"},{"issue":"2","key":"1924_CR103","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","volume":"5","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 2015;5(2):123\u20137.","journal-title":"3 Biotech"},{"issue":"2","key":"1924_CR104","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.nano.2016.08.011","volume":"13","author":"MH Lin","year":"2017","unstructured":"Lin MH, Hung CF, Aljuffali IA, Sung CT, Huang CT, Fang JY. Cationic amphiphile in phospholipid bilayer or oil\u2013water interface of nanocarriers affects planktonic and biofilm bacteria killing. Nanomed Nanotechnol Biol Med. 2017;13(2):353\u201361.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"3","key":"1924_CR105","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41578-019-0161-9","volume":"5","author":"T Sheth","year":"2020","unstructured":"Sheth T, Seshadri S, Prileszky T, Helgeson ME. Multiple nanoemulsions. Nat Reviews Mater. 2020;5(3):214\u201328.","journal-title":"Nat Reviews Mater"},{"key":"1924_CR106","doi-asserted-by":"crossref","unstructured":"Souto EB, Cano A, Martins-Gomes C, Coutinho TE, Zieli\u0144ska A, Silva AM. Microemulsions and nanoemulsions in skin drug delivery. Bioeng (Basel). 2022;9(4).","DOI":"10.3390\/bioengineering9040158"},{"key":"1924_CR107","doi-asserted-by":"crossref","unstructured":"Ullah I, Alhodaib A, Naz I, Ahmad W, Ullah H, Amin A et al. Fabrication of novel Omeprazole-Based Chitosan coated nanoemulgel formulation for potential Anti-Microbia; in vitro and ex vivo characterizations. Polym (Basel). 2023;15(5).","DOI":"10.3390\/polym15051298"},{"key":"1924_CR108","doi-asserted-by":"crossref","unstructured":"Nastiti C, Ponto T, Abd E, Grice JE, Benson HAE, Roberts MS. Topical nano and microemulsions for skin delivery. Pharmaceutics. 2017;9(4).","DOI":"10.3390\/pharmaceutics9040037"},{"issue":"11","key":"1924_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12111091","volume":"12","author":"T Muta","year":"2020","unstructured":"Muta T, Parikh A, Kathawala K, Haidari H, Song Y, Thomas J, et al. Quality-by-design approach for the development of nano-sized tea tree oil formulation-impregnated biocompatible gel with antimicrobial properties. Pharmaceutics. 2020;12(11):1\u201316.","journal-title":"Pharmaceutics"},{"issue":"6","key":"1924_CR110","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W. Lipid-Based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au. 2023;3(6):600\u201319.","journal-title":"ACS Mater Au"},{"key":"1924_CR111","doi-asserted-by":"crossref","unstructured":"El-Naggar MM, El-Nabarawi MA, Teaima MH, Hassan M, Hamed MIA, Elrashedy AA et al. Integration of terpesomes loaded Levocetrizine dihydrochloride gel as a repurposed cure for Methicillin-Resistant Staphylococcus aureus (MRSA)-Induced skin infection; D-optimal optimization, ex-vivo, in-silico, and in-vivo studies. Int J Pharm. 2023;633.","DOI":"10.1016\/j.ijpharm.2023.122621"},{"key":"1924_CR112","doi-asserted-by":"crossref","unstructured":"Gitte M, Gomte SS, Agnihotri TG, Singh N, Jain A. Development of amoxicillin Trihydrate-Loaded lyotropic liquid crystal nanoparticles for skin infection. J Mol Liq. 2023;374.","DOI":"10.1016\/j.molliq.2023.121281"},{"key":"1924_CR113","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.2147\/IJN.S147226","volume":"12","author":"CY Hsu","year":"2017","unstructured":"Hsu CY, Yang SC, Sung CT, Weng YH, Fang JY. Anti-MRSA malleable liposomes carrying Chloramphenicol for ameliorating hair follicle targeting. Int J Nanomed. 2017;12:8227\u201338.","journal-title":"Int J Nanomed"},{"issue":"1\u20132","key":"1924_CR114","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijpharm.2018.10.024","volume":"553","author":"Z Rukavina","year":"2018","unstructured":"Rukavina Z, Klaric MS, Grcic JF, Lovric J, Vanic Z. Azithromycin-loaded liposomes for enhanced topical treatment of methicillin-resistant Staphyloccocus aureus (MRSA) infections. Int J Pharm. 2018;553(1\u20132):109\u201319.","journal-title":"Int J Pharm"},{"issue":"7","key":"1924_CR115","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.5958\/0974-360X.2018.00557.7","volume":"11","author":"SK Sahu","year":"2018","unstructured":"Sahu SK, Ram A. Evaluation of linezolid loaded ethosomes for treatment of deep skin infections in diabetic model. Res J Pharm Technol. 2018;11(7):3023\u201330.","journal-title":"Res J Pharm Technol"},{"issue":"8","key":"1924_CR116","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1080\/03639045.2020.1788068","volume":"46","author":"S Salatin","year":"2020","unstructured":"Salatin S, Jelvehgari M. Desirability function approach for development of a thermosensitive and bioadhesive nanotransfersome-hydrogel hybrid system for enhanced skin bioavailability and antibacterial activity of cephalexin. Drug Dev Ind Pharm. 2020;46(8):1318\u201333.","journal-title":"Drug Dev Ind Pharm"},{"key":"1924_CR117","doi-asserted-by":"publisher","first-page":"7639","DOI":"10.2147\/IJN.S325901","volume":"16","author":"S Sangboonruang","year":"2021","unstructured":"Sangboonruang S, Semakul N, Obeid MA, Ruano M, Kitidee K, Anukool U, et al. Potentiality of Melittin-Loaded Niosomal vesicles against Vancomycin-Intermediate Staphylococcus aureus and Staphylococcal skin infection. Int J Nanomed. 2021;16:7639\u201361.","journal-title":"Int J Nanomed"},{"key":"1924_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9516-5_1","volume":"2000","author":"S Wadhwa","year":"2019","unstructured":"Wadhwa S, Garg V, Gulati M, Kapoor B, Singh SK, Mittal N. Nanovesicles for nanomedicine: theory and practices. Methods Mol Biol. 2019;2000:1\u201317.","journal-title":"Methods Mol Biol"},{"key":"1924_CR119","doi-asserted-by":"crossref","unstructured":"Zakaria MY, Eraqi WA, Mohamed SA. Ultra-deformable free fatty acid based nano-carriers for topical delivery of luteolin: A potential paradigm for management of Methicillin-Resistant Staphylococcus aureus skin infections. Int J Pharm. 2023;643.","DOI":"10.1016\/j.ijpharm.2023.123259"},{"issue":"5","key":"1924_CR120","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jsps.2023.03.016","volume":"31","author":"H Ali","year":"2023","unstructured":"Ali H, Akbar M, Iqbal B, Ali F, Sharma NK, Kumar N, et al. Virosome: an engineered virus for vaccine delivery. Saudi Pharm J. 2023;31(5):752\u201364.","journal-title":"Saudi Pharm J"},{"key":"1924_CR121","doi-asserted-by":"crossref","unstructured":"Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27(4).","DOI":"10.3390\/molecules27041372"},{"key":"1924_CR122","unstructured":"Arshad N, Farwa S, Noor KI, Saba N, Maria R, Irfan SM et al. A comprehensive review on niosomes: novel manufacturing techniques, factors influencing formation, applications and recent advances. Int J Polym Mater Polym Biomater.1\u201318."},{"issue":"3","key":"1924_CR123","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/2211738511666230726154557","volume":"12","author":"S Sharma","year":"2024","unstructured":"Sharma S, Garg A, Agrawal R, Chopra H, Pathak D. A comprehensive review on niosomes as a tool for advanced drug delivery. Pharm Nanotechnol. 2024;12(3):206\u201328.","journal-title":"Pharm Nanotechnol"},{"issue":"5","key":"1924_CR124","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1208\/s12249-024-02822-w","volume":"25","author":"Q Fang","year":"2024","unstructured":"Fang Q, Li Y, Xiong F, Hu X, Song Y, Shen W, et al. Formulation and characterization of ethosomes for transdermal delivery of Prinsepia utilis Rogle seed oil with ameliorative effects against UVB-Induced skin damage. AAPS PharmSciTech. 2024;25(5):122.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1924_CR125","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12951-024-02860-3","volume":"22","author":"P Wang","year":"2024","unstructured":"Wang P, Hong S, Cao C, Guo S, Wang C, Chen X, et al. Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis. J Nanobiotechnol. 2024;22(1):584.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1924_CR126","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40360-024-00742-w","volume":"25","author":"J Wu","year":"2024","unstructured":"Wu J, Xu R, Xu X, Ye S, Huang A. Preparation and evaluation of transdermal permeation of huperzine A ethosomes gel in vitro. BMC Pharmacol Toxicol. 2024;25(1):21.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"8","key":"1924_CR127","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s11095-021-03079-9","volume":"38","author":"J Liu","year":"2021","unstructured":"Liu J, Zheng A, Peng B, Xu Y, Zhang N. Size-Dependent absorption through stratum corneum by Drug-Loaded liposomes. Pharm Res. 2021;38(8):1429\u201337.","journal-title":"Pharm Res"},{"issue":"2","key":"1924_CR128","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1248\/bpb.30.350","volume":"30","author":"G Garg","year":"2007","unstructured":"Garg G, Saraf S, Saraf S. Cubosomes: an overview. Biol Pharm Bull. 2007;30(2):350\u20133.","journal-title":"Biol Pharm Bull"},{"key":"1924_CR129","doi-asserted-by":"crossref","unstructured":"Sivadasan D, Sultan MH, Alqahtani SS, Javed S. Cubosomes in drug Delivery\u2014A comprehensive review on its structural components, Preparation techniques and therapeutic applications. Biomedicines [Internet]. 2023; 11(4).","DOI":"10.3390\/biomedicines11041114"},{"key":"1924_CR130","doi-asserted-by":"crossref","unstructured":"Sivadasan D, Sultan MH, Alqahtani SS, Javed S. Cubosomes in drug Delivery-A comprehensive review on its structural components, Preparation techniques and therapeutic applications. Biomedicines. 2023;11(4).","DOI":"10.3390\/biomedicines11041114"},{"issue":"1","key":"1924_CR131","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5530\/jyp.20251440","volume":"17","author":"MA Mustafa","year":"2025","unstructured":"Mustafa MA, Rasheed N, Ayesha M, ul Ain Q, Mughal M, Fahad M, et al. Novasomes: A versatile drug delivery system for enhanced therapeutic efficacy. J Young Pharmacists. 2025;17(1):36\u201345.","journal-title":"J Young Pharmacists"},{"key":"1924_CR132","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/IJN.S287383","volume":"16","author":"S Mosallam","year":"2021","unstructured":"Mosallam S, Ragaie MH, Moftah NH, Elshafeey AH, Abdelbary AA. Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: in vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomed. 2021;16:119\u201332.","journal-title":"Int J Nanomed"},{"key":"1924_CR133","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.2147\/IJN.S283911","volume":"15","author":"MA Tawfik","year":"2020","unstructured":"Tawfik MA, Tadros MI, Mohamed MI, El-Helaly SN. Low-frequency versus high-frequency ultrasound-mediated transdermal delivery of agomelatine-loaded invasomes: development, optimization and in-vivo Pharmacokinetic assessment. Int J Nanomed. 2020;15:8893\u2013910.","journal-title":"Int J Nanomed"},{"key":"1924_CR134","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/978-3-642-22144-6_160","volume-title":"Natural products: phytochemistry, botany and metabolism of alkaloids, phenolics and terpenes","author":"L Kang","year":"2013","unstructured":"Kang L, Kumar VH, Lim PFC, Cheong HH, Chan SY. Terpenes and improvement of transdermal drug delivery. In: Ramawat KG, M\u00e9rillon J-M, editors. Natural products: phytochemistry, botany and metabolism of alkaloids, phenolics and terpenes. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. pp. 3757\u201374."},{"issue":"2","key":"1924_CR135","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00210-023-02670-8","volume":"397","author":"HA Simrah","year":"2024","unstructured":"Simrah HA, Usmani SA, Izhar MP. Transfersome, an ultra-deformable lipid-based drug nanocarrier: an updated review with therapeutic applications. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2024;397(2):639\u201373.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"27","key":"1924_CR136","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2217\/nnm-2021-0335","volume":"16","author":"P Oyarz\u00fan","year":"2021","unstructured":"Oyarz\u00fan P, Eduardo G-T, Javier M, Arriagada F. Transfersomes as alternative topical nanodosage forms for the treatment of skin disorders. Nanomedicine. 2021;16(27):2465\u201389.","journal-title":"Nanomedicine"},{"issue":"29","key":"1924_CR137","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.2174\/1381612828666220728112741","volume":"28","author":"S Kulkarni","year":"2022","unstructured":"Kulkarni S, Prabhakar B, Shende P, Aquasomes. Advanced Vesicular-based nanocarrier systems. Curr Pharm Des. 2022;28(29):2404\u201314.","journal-title":"Curr Pharm Des"},{"issue":"3s","key":"1924_CR138","doi-asserted-by":"publisher","first-page":"s757","DOI":"10.5530\/ijper.58.3s.77","volume":"58","author":"V Sahu","year":"2024","unstructured":"Sahu V, Sahoo SK, Sahoo AC. Aquasome: as drug delivery carrier in the pharmaceutical field. Indian J Pharm Educ Res. 2024;58(3s):s757\u201367.","journal-title":"Indian J Pharm Educ Res"},{"issue":"1","key":"1924_CR139","doi-asserted-by":"publisher","first-page":"2367849","DOI":"10.1080\/20565623.2024.2367849","volume":"10","author":"B Shanmugam","year":"2024","unstructured":"Shanmugam B, Srinivasan UM. Formulation and characterization of antibiotic drug loaded Aquasome for the topical application. Future Sci OA. 2024;10(1):2367849.","journal-title":"Future Sci OA"},{"key":"1924_CR140","doi-asserted-by":"crossref","unstructured":"L\u00f3pez KL, Ravasio A, Gonz\u00e1lez-Aramundiz JV, Zacconi FC. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) prepared by microwave and Ultrasound-Assisted synthesis: promising green strategies for the nanoworld. Pharmaceutics. 2023;15(5).","DOI":"10.3390\/pharmaceutics15051333"},{"key":"1924_CR141","doi-asserted-by":"crossref","unstructured":"Alalaiwe A, Wang PW, Lu PL, Chen YP, Fang JY, Yang SC. Synergistic anti-MRSA activity of cationic nanostructured lipid carriers in combination with oxacillin for cutaneous application. Front Microbiol. 2018;9(JUL).","DOI":"10.3389\/fmicb.2018.01493"},{"key":"1924_CR142","doi-asserted-by":"crossref","unstructured":"de Barros DPC, Reed P, Alves M, Santos R, Oliva A. Biocompatibility and antimicrobial activity of nanostructured lipid carriers for topical applications are affected by type of oils used in their composition. Pharmaceutics. 2021;13(11).","DOI":"10.3390\/pharmaceutics13111950"},{"key":"1924_CR143","doi-asserted-by":"crossref","unstructured":"de Barros DPC, Santos R, Reed P, Fonseca LP, Oliva A. Design of Quercetin-Loaded natural Oil-Based nanostructured lipid carriers for the treatment of bacterial skin infections. Molecules. 2022;27(24).","DOI":"10.3390\/molecules27248818"},{"issue":"7","key":"1924_CR144","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1208\/s12249-022-02381-y","volume":"23","author":"K Rajpoot","year":"2022","unstructured":"Rajpoot K, Prajapati SK, Malaiya A, Jain R, Jain A. Meropenem-Loaded nanostructured lipid carriers for skin and soft tissue infection caused by Staphylococcus aureus: formulation, design, and evaluation. AAPS PharmSciTech. 2022;23(7):241.","journal-title":"AAPS PharmSciTech"},{"key":"1924_CR145","doi-asserted-by":"crossref","unstructured":"Shinde G, Sonchhatra A, Shelke S, Pathan I. Design, optimization and in-vivo characterization of mupirocin loaded nanostructured lipid carrier based gel for effective treatment of impetigo. J Drug Deliv Sci Technol. 2022;67.","DOI":"10.1016\/j.jddst.2021.102872"},{"issue":"4","key":"1924_CR146","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2174\/0127724344280309240103062810","volume":"19","author":"I Chauhan","year":"2024","unstructured":"Chauhan I, Singh L. Formulation and optimization of solid lipid Nanoparticle-based gel for dermal delivery of linezolid using Taguchi design. Recent Adv Anti-Infect Drug Discov. 2024;19(4):322\u201347.","journal-title":"Recent Adv Anti-Infect Drug Discov"},{"issue":"5","key":"1924_CR147","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s13346-023-01307-w","volume":"13","author":"L-H Chuah","year":"2023","unstructured":"Chuah L-H, Loo H-L, Goh CF, Fu J-Y, Ng S-F. Chitosan-based drug delivery systems for skin atopic dermatitis: recent advancements and patent trends. Drug Deliv Transl Res. 2023;13(5):1436\u201355.","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"1924_CR148","doi-asserted-by":"publisher","first-page":"218","DOI":"10.34172\/apb.2023.028","volume":"13","author":"R Kotha","year":"2023","unstructured":"Kotha R, Kara DD, Roychowdhury R, Tanvi K, Rathnanand M. Polymersomes based versatile nanoplatforms for controlled drug delivery and imaging. Adv Pharm Bull. 2023;13(2):218\u201332.","journal-title":"Adv Pharm Bull"},{"issue":"3","key":"1924_CR149","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/wnan.1211","volume":"5","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5(3):205\u201318.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1924_CR150","doi-asserted-by":"crossref","unstructured":"Abo-Zeid Y, Bakkar MR, Elkhouly GE, Raya NR, Zaafar D. Rhamnolipid Nano-Micelles versus Alcohol-Based Hand Sanitizer: A Comparative Study for Antibacterial Activity against Hospital-Acquired Infections and Toxicity Concerns. ANTIBIOTICS-BASEL. 2022;11(5).","DOI":"10.3390\/antibiotics11050605"},{"issue":"2\u20133","key":"1924_CR151","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0168-3659(02)00142-6","volume":"82","author":"H Lboutounne","year":"2002","unstructured":"Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirot F. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(\u03b5-caprolactone) nanocapsule encapsulated form and as a digluconate. J Control Release. 2002;82(2\u20133):319\u201334.","journal-title":"J Control Release"},{"key":"1924_CR152","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. 2020;25(16).","DOI":"10.3390\/molecules25163731"},{"key":"1924_CR153","doi-asserted-by":"crossref","unstructured":"Thamilselvan G, David H, Sajeevan A, Rajaramon S, Solomon AP, Durai RD et al. Polymer based dual drug delivery system for targeted treatment of fluoroquinolone resistant Staphylococcus aureus mediated infections. Sci Rep. 2023;13(1).","DOI":"10.1038\/s41598-023-38473-3"},{"key":"1924_CR154","doi-asserted-by":"crossref","unstructured":"Turkmen E, Parmaksiz S, Nigiz S, Sagiroglu M, Senel S. A safe bioadhesive system for topical delivery of combined antimicrobials in treatment of skin infections in veterinary medicine. J Drug Deliv Sci Technol. 2023;80.","DOI":"10.1016\/j.jddst.2022.104116"},{"key":"1924_CR155","doi-asserted-by":"crossref","unstructured":"Zaharieva MM, Kaleva M, Kroumov A, Slavkova M, Benbassat N, Yoncheva K et al. Advantageous combinations of nanoencapsulated oregano oil with selected antibiotics for skin treatment. Pharmaceutics. 2022;14(12).","DOI":"10.3390\/pharmaceutics14122773"},{"issue":"2","key":"1924_CR156","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/acs.molpharmaceut.2c00960","volume":"20","author":"N Ramzan","year":"2023","unstructured":"Ramzan N, Abbas G, Mahmood K, Aziz M, Rasul S, Ahmed N, et al. Concomitant effect of Quercetin and its copper complex in the development of Sustained-Release nanoparticles of polycaprolactone, used for the treatment of skin infection. Mol Pharm. 2023;20(2):1382\u201393.","journal-title":"Mol Pharm"},{"issue":"9","key":"1924_CR157","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric nanoparticles for drug delivery. Chem Rev. 2024;124(9):5505\u2013616.","journal-title":"Chem Rev"},{"key":"1924_CR158","doi-asserted-by":"publisher","first-page":"103890","DOI":"10.1016\/j.jddst.2022.103890","volume":"77","author":"BS Sivamaruthi","year":"2022","unstructured":"Sivamaruthi BS, Nallasamy Pk, Suganthy N, Kesika P, Chaiyasut C. Pharmaceutical and biomedical applications of starch-based drug delivery system: A review. J Drug Deliv Sci Technol. 2022;77:103890.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"11","key":"1924_CR159","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1007\/s13346-022-01139-0","volume":"12","author":"SK Einipour","year":"2022","unstructured":"Einipour SK, Sadrjahani M, Rezapour A. Preparation and evaluation of antibacterial wound dressing based on vancomycin-loaded silk\/dialdehyde starch nanoparticles. Drug Deliv Transl Res. 2022;12(11):2778\u201392.","journal-title":"Drug Deliv Transl Res"},{"key":"1924_CR160","doi-asserted-by":"crossref","unstructured":"Montanari E, Oates A, Di Meo C, Meade J, Cerrone R, Francioso A et al. Hyaluronan-Based nanohydrogels for targeting intracellular S-Aureus in human keratinocytes. Adv Healthc Mater. 2018;7(12).","DOI":"10.1002\/adhm.201701483"},{"issue":"6","key":"1924_CR161","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/17425247.2020.1764530","volume":"17","author":"S Salatin","year":"2020","unstructured":"Salatin S, Lotfipour F, Jelvehgari M. Preparation and characterization of a novel thermosensitive and bioadhesive cephalexin nanohydrogel: a promising platform for topical antibacterial delivery. Expert Opin Drug Deliv. 2020;17(6):881\u201393.","journal-title":"Expert Opin Drug Deliv"},{"issue":"8","key":"1924_CR162","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1080\/10837450.2021.1948570","volume":"26","author":"Z Ay \u015eenyi\u011fit","year":"2021","unstructured":"Ay \u015eenyi\u011fit Z, Co\u015fkunmeri\u00e7 N, \u00c7a\u011flar E, \u00d6zt\u00fcrk \u0130, Atl\u0131han G\u00fcndo\u011fdu E, Siafaka PI, et al. Chitosan-bovine serum albumin-Carbopol 940 nanogels for mupirocin dermal delivery: ex-vivo permeation and evaluation of cellular binding capacity via radiolabeling. Pharm Dev Technol. 2021;26(8):852\u201366.","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"1924_CR163","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/026520499289077","volume":"16","author":"VB Patel","year":"1999","unstructured":"Patel VB, Misra AN. Encapsulation and stability of Clofazimine liposomes. J Microencapsul. 1999;16(3):357\u201367.","journal-title":"J Microencapsul"},{"key":"1924_CR164","unstructured":"Hauser C, Loo Y. inventors; agency science tech & res, assignee. Novel ultrashort hydrophobic peptides that self-assemble into nanofibrous hydrogels and their uses. WO patent WO 2015\/080670 A1. 2015 2014\/11\/28."},{"issue":"1","key":"1924_CR165","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1021\/acs.biomac.4c01296","volume":"26","author":"G Saenz","year":"2025","unstructured":"Saenz G, Pogostin BH, Cole CC, Agrawal A, Chew-Martinez D, Dubackic M, et al. Nanofibrous peptide hydrogels leveraging histidine to modulate pH-Responsive supramolecular assembly and antibody release. Biomacromolecules. 2025;26(1):490\u2013502.","journal-title":"Biomacromolecules"},{"key":"1924_CR166","unstructured":"De Beer J. Beer Joel, assignee. Hybridosomes, compositions comprising the same, processes for their production and uses thereof. Wo patent wo 2015\/110957 a2. 2015 2015\/01\/20."},{"key":"1924_CR167","doi-asserted-by":"crossref","unstructured":"Peng Q, Tang X, Dong W, Sun N, Yuan W. A review of biofilm formation of Staphylococcus aureus and its regulation mechanism. Antibiot (Basel). 2022;12(1).","DOI":"10.3390\/antibiotics12010012"},{"key":"1924_CR168","unstructured":"Noel Scott P, Shumpert John K, Greene A, Austin William B. inventors; PROMEND ANIMAL HEALTH INC, assignee. Compositions and methods for treating wounds. WO patent WO 2018\/226479 A1. 2018 2018\/05\/30."},{"key":"1924_CR169","unstructured":"Noel Scott P, Shumpert John K, Greene A, Austin William B. inventors; Promend animal health inc, assignee. Compositions and methods for treating wounds. US patent US 2020\/0129564 A1. 2020 2018\/05\/30."},{"key":"1924_CR170","doi-asserted-by":"crossref","unstructured":"Iaconis A, De Plano LM, Caccamo A, Franco D, Conoci S. Anti-Biofilm strategies: A focused review on innovative approaches. Microorganisms. 2024;12(4).","DOI":"10.3390\/microorganisms12040639"},{"key":"1924_CR171","unstructured":"Thorn C, Thomas N, Prestidge C. inventors; univ South australia, assignee. Antimicrobial compositions and methods of use. WO patent WO 2022\/077060 A1. 2022 2021\/10\/13."},{"key":"1924_CR172","unstructured":"Thorn C, Thomas N, Prestidge C. inventors; UNIV SOUTH AUSTRALIA, assignee. Antimicrobial compositions and methods of use. US patent US 2023\/0390316 A1. 2023 2021\/10\/13."},{"key":"1924_CR173","unstructured":"De Silva Teixeira C\u00c1Tia CGPA, Martins Gomes Ana A. S, Lobo Machado Gameiro Dos Santos Alberta P, Da Cruz Batista Mateus Nuno F, Reis Fernandes Iva L, inventors; Univ Do Porto Requimte Rede De Quim E Tecnologia Inst Politecnico Do Porto, assignee. Peptide-ionic liquid conjugate for the prevention and\/or treatment of skin disorders. WO patent WO 2023\/248196 A1. 2023 2023\/06\/23."},{"key":"1924_CR174","doi-asserted-by":"publisher","first-page":"115139","DOI":"10.1016\/j.addr.2023.115139","volume":"203","author":"T Zhang","year":"2023","unstructured":"Zhang T, Luo X, Xu K, Zhong W. Peptide-containing nanoformulations: skin barrier penetration and activity contribution. Adv Drug Deliv Rev. 2023;203:115139.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10369","key":"1924_CR175","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"KS Ikuta","year":"2022","unstructured":"Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10369):2221\u201348.","journal-title":"Lancet"},{"key":"1924_CR176","unstructured":"WHO. WHO bacterial priority pathogens list. 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization. Updated May 17, 2024. Accessed April 25, 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240093461"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01924-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01924-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01924-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:04:00Z","timestamp":1759932240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01924-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":176,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01924-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"10 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}